133690-92-3

Basic information

• Product Name: 4'-(aminomethyl)biphenyl-2-carbonitrile
• Synonyms: 4'-(aminomethyl)biphenyl-2-carbonitrile;2-[4-(aMinoMethyl)phenyl]benzonitrile;4'-(Aminomethyl)-biphenyl-2-carbonitrile HCl
• CAS NO: 133690-92-3
• Molecular Formula: C₁₄H₁₂N₂
• Molecular Weight: 208.263
• Mol File: 133690-92-3.mol
• Article Data: 12

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 4'-(aminomethyl)biphenyl-2-carbonitrile(CAS DataBase Reference)
• NIST Chemistry Reference: 4'-(aminomethyl)biphenyl-2-carbonitrile(133690-92-3)
• EPA Substance Registry System: 4'-(aminomethyl)biphenyl-2-carbonitrile(133690-92-3)

Safety Data

• Hazardous Substances Data: 133690-92-3(Hazardous Substances Data)

Upstream product

• 7732-18-5 water 
• 603-35-0 triphenylphosphine 
• 133690-91-2 4'-(azidomethyl)[1,1'-biphenyl]-2-carbonitrile 
• 4403-71-8 (4-aminomethyl)aniline 
• 914452-61-2 α-benzyloxycarbonylamino-p-toluoylboronic acid 
• 168050-39-3 [(4-Aminophenyl)methyl]carbamic acid,phenylmethyl ester 
• 3959-07-7 4-Bromobenzylamine 
• 138642-62-3 2-Cyanophenylboronic acid 
• 114772-53-1 2-Cyano-4'-methylbiphenyl 
• 114772-54-2 4'-(bromomethyl)-1,1'-biphenyl-2-carbonitrile 

Downstream Products

• 244127-50-2 4'-<(3-ethyl-5-methylpyrazolo<1,5-a>pyrimidin-7-yl)aminomethyl>biphenyl-2-carbonitrile 
• 244127-47-7 4'-<(5-phenylpyrazolo<1,5-a>pyrimidin-7-yl)aminomethyl>biphenyl-2-carbonitrile 
• 866946-42-1 2-(4-aminomethylphenyl)benzamide 
• 909131-34-6 1-propionylamino-cyclohexanecarboxylic acid (2'-cyano-biphenyl-4-ylmethyl)-amide 
• 244127-51-3 4'-<(5-ethyl-3-phenylpyrazolo<1,5-a>pyrimidin-7-yl)aminomethyl>biphenyl-2-carbonitrile 
• 167371-92-8 ethyl 7-<(2'-cyanobiphenyl-4-yl)methylamino>-5-ethylpyrazolo<1,5-a>pyrimidine-3-carboxylate 
• 167372-02-3 4'-<(5-ethyl-3-propylpyrazolo<1,5-a>pyrimidin-7-yl)aminomethyl>biphenyl-2-carbonitrile 
• 167371-58-6 4'-<(3,5-diethylpyrazolo<1,5-a>pyrimidin-7-yl)aminomethyl>biphenyl-2-carbonitrile 
• 244127-52-4 4'-<(5-ethyl-3-methoxypyrazolo<1,5-a>pyrimidin-7-yl)aminomethyl>biphenyl-2-carbonitrile 
• 244127-49-9 4'-<(5-ethyl-3-methylpyrazolo<1,5-a>pyrimidin-7-yl)aminomethyl>biphenyl-2-carbonitrile 
• 167371-46-2 4'-<(3-chloro-5-ethylpyrazolo<1,5-a>pyrimidin-7-yl)aminomethyl>biphenyl-2-carbonitrile 
• 244127-46-6 4'-<(5-propylpyrazolo<1,5-a>pyrimidin-7-yl)aminomethyl>biphenyl-2-carbonitrile 
• 244127-48-8 4'-<(3,5-dimethylpyrazolo<1,5-a>pyrimidin-7-yl)aminomethyl>biphenyl-2-carbonitrile 
• 167371-43-9 4'-<(5-ethylpyrazolo<1,5-a>pyrimidin-7-yl)aminomethyl>biphenyl-2-carbonitrile 

Relevant articles and documents

New technology for preparing azilsartan

The invention relates to a preparation method for azilsartan. The method is characterized by comprising the following steps: enabling 2-fluorine-3-bromine nitrobenzene to react with a midbody 3 prepared from suzuki reaction, replacing 2 fluorines and then reducing by nitro group; reacting with tetraethyl orthocarbonate, closing the ring and forming a benzimidazole ring; reacting with hydroxylamine hydrochloride and compounding a phenyl substituted oxadiazole ring under the effect of CDI; forming formic acid with carbon dioxide under the catalysis of n-butyllithium, thereby acquiring the product. The preparation method has the advantages of easily acquired raw materials, simple process, high overall yield, few side products, simplicity in post-processing and suitability for industrial production.

Anti-Inflammation Compounds

The present invention refers to: a compound having the general formula (I), wherein n is 0, 1, 2 or; m is 0, 1, 2 or 3; o is 0, 1, 2 or 3; W, X, Y and Z are independently selected from CH, N or N-oxide; A is NR4, C═O, C═S, OP(O)(O), P═O, CH2, or a heteroarly selected from the group consisting of (a), (b), (c), (d), (e), (f), (g); V is C═O, O, S, CH2, or NR5; as well as its use in treating inflammatory diseases such as asthma, COPD, inflammation post infection, arthritis, atherosclerosis, pain and dermatitis.

AN IMPROVED PROCESS FOR THE PREPARATION OF IRBESARTAN

The present invention relates to an improved process for the preparation of 2-n-butyl-3-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]-1,3-diazaspiro[4.4]non-1-en-4-one (Irbesartan)